Health ❯Public Health

Vaccines

Vaccines Vaccination Health Policy Vaccines Public Health Vaccine Development FDA Health Policy FDA FDA

FDA Expands Heart Risk Warnings for Pfizer and Moderna COVID-19 Vaccines

New labels highlight myocarditis risks in males aged 16 to 25 as Senate report probes delayed public warnings by U.S. health officials.

Stories older than 24h

FDA Shifts COVID-19 Vaccine Policy to Focus on High-Risk Groups

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine

HHS to End Routine COVID-19 Vaccine Recommendations for Children and Pregnant People

Measles Outbreak Surpasses 1,000 Cases Amid RFK Jr.'s Vaccine Misinformation

FDA Appoints Vaccine Critic Vinay Prasad as New Biologics Chief

Public Trust in FDA and CDC Remains Low, Shaped by Partisan Shifts and Misinformation

HHS Mandates Placebo Trials for New Vaccines, Raising Concerns Over COVID Booster Delays

HHS and NIH Launch $500 Million Universal Vaccine Initiative Using Whole-Virus Approach

FDA Demands New Trials for Novavax COVID Vaccine, Raising Concerns Over Fall Booster Rollouts

Merck Lowers 2025 Profit Forecast as Tariffs and Licensing Costs Weigh

HHS Secretary Kennedy Faces Backlash Over Vaccine Stance and Autism Research Plans

RFK Jr.’s Autism Research Plan Draws Backlash Over Discredited Vaccine Theories

John Rich's Advice to Trump Shaped Vaccine Messaging Strategy

HHS Layoffs Begin as RFK Jr. Restructures Federal Health Agencies

FDA Vaccine Chief Resigns, Citing Kennedy's 'Misinformation and Lies'

HHS Faces Backlash Over Appointment of Discredited Researcher for Vaccine Study

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020

NIH Directs Scientists to Remove mRNA Vaccine References, Raising Fears of Research Cuts

CDC Nominee Withdrawn Over Vaccine Safety Controversy